RAB11A and prostate cancer: The upregulation of recycling endosomes in prostate cancer (such as RAB4 and RAB11A) [42,65] and altered trafficking and disrupted endosome biogenesis may enhance the transport of ADCs back to the plasma membrane and limit the delivery to the acidic compartments required to release the MMAE.